Eton Pharma (ETON) - Bozor qiymatining balans qiymatiga nisbati

Eton Pharma - ETON emitenti grafik logotipi

Eton Pharmaceuticals (ETON) biologik parchalanuvchi qadoqlash va ekologik toza chiqindilarni yo'q qilish orqali ESG tamoyillarini joriy qilmoqda, bu esa GURU.Markets platformasidagi narxlar harakati grafigi bilan tasdiqlanadi, u yerda ko'rsatkich 31.27 qiymatida qat'iy belgilangan. Biznes barqarorligi FDA ekspertlaridan iborat ixcham shtat va autsorsing asosidagi ishlab chiqarishga tayanadi. Endokrin patologiyalar uchun davolash vositalarining noyob portfeli samaradorlikni yanada oshirib, yopiq terapevtik siklni yaratmoqda.

Eton Corp (ETON) Sof aktivlarga nisbatan bozor kapitallashuvi: 04.07.2022 - 29.10.2026 davri uchun
Eton Pharmaceuticals Inc yetakchi tovari

Ushbu ko'rsatkich Eton Pharmaceuticals (ETON) kompaniyasining bozor qiymatini uning sof aktivlari bilan solishtirib, tashqi shoklar paytidagi kapitalning keskin haddan tashqari yuqori baholanishini aniqlaydi. Kamyob endokrin patologiyalar uchun zarur dori vositalarini ishlab chiqayotgan kompaniya uchun intellektual mulk qiymatidagi har qanday o'zgarishlar P/B ko'rsatkichi orqali kompaniyaning baholash tarixida zudlik bilan aks etadi va investorlarni shishirilgan narxda kirish xavfi haqida ogohlantiradi.

Raqobatchilar tahlili

Vertex Pharmaceuticals (VRTX) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati ALNY|Bozor qiymatining balans qiymatiga nisbati Insmed|United Therapeutics Corp (UTHR) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati BioMarin Pharma (BMRN)|BBIO: Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati BGM (BGM Group)|cogentbio.com (COGT) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Xeris Biopharma Holdings - Bozor kapitallashuvining balans qiymatiga nisbati|Keros Therapeutics Inc (KROS) - Kapitallashuvning sof aktivlarga nisbati|ARCT: Bozor kapitallashuvining balans qiymatiga nisbati|KMDA - Balans qiymatiga nisbatan bozor kapitallashuvi|FULC (Fulcrum Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Abeona|Bozor qiymatining balans qiymatiga nisbati Mereo BioPharma (MREO)|Bozor qiymatining balans qiymatiga nisbati PLX (Protalix BioTherapeutics Inc.)|Bozor kapitallashuvining balans qiymatiga nisbati PLRX (Pliant Therapeutics, Inc.)|Balans qiymatiga nisbatan bozor kapitallashuvi Applied Therapeutics Inc. (APLT)|RNTX: Kapitallashuvning sof aktivlarga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi GELS|AYTU: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Chemomab Therapeutics Ltd. (CMMB)|SRXH (SRx Health Solutions Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati PLRZ (Polyrizon Ltd.)|Kapitallashuvning sof aktivlarga nisbati AEZS (Aeterna Zentaris)|CYTH (cyclotherapeutics.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Inozyme Pharma INZY|RPHM (Reneo Pharmaceuticals Inc.) - Sof aktivlarga nisbatan bozor kapitallashuvi|Aeterna Zentaris - Bozor kapitallashuvining balans qiymatiga nisbati